Studies of recombinant HA proteins with different adjuvants for avian influenza H7N9 mucosal vaccine development

Studies of recombinant HA proteins with different adjuvants for avian influenza H7N9 mucosal vaccine development

碩士 === 國立清華大學 === 生物科技研究所 === 103 === 因申請專利緣故，資料延後公開

Bibliographic Details
Main Authors:	Wu, Jian-Hsin, 吳建欣
Other Authors:	Wu, Suh-Chin
Format:	Others
Language:	zh-TW
Published:	2015
Online Access:	http://ndltd.ncl.edu.tw/handle/43737b

Similar Items

Use of PELC/CpG Adjuvant for Intranasal Immunization with Recombinant Hemagglutinin to Develop H7N9 Mucosal Vaccine
by: Ting-Hsuan Chen, et al.
Published: (2020-05-01)

Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens
by: Zhou Sha, et al.
Published: (2020-03-01)

Assessing the efficacy of a recombinant H9N2 avian influenza virus–inactivated vaccine
by: Cai Liang Song, et al.
Published: (2020-09-01)

Generation and Evaluation of Recombinant Thermostable Newcastle Disease Virus Expressing the HA of H9N2 Avian Influenza Virus
by: Xiaorong Zhang, et al.
Published: (2021-08-01)

Studies on the development of adjuvants and inactivated vaccines of avian influenza
by: DAI, SHI-YUAN, et al.
Published: (1993)

Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.
by: Li Song, et al.
Published: (2016-01-01)

Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults
by: Christine M. Oshansky, et al.
Published: (2021-03-01)

Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines.
by: Shih-Chang Lin, et al.
Published: (2011-01-01)

Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant
by: Tao Qin, et al.
Published: (2020-09-01)

Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults
by: Athena P. Y. Li, et al.
Published: (2021-02-01)

Evaluation of several adjuvants in avian influenza vaccine to chickens and ducks
by: Li Hong T, et al.
Published: (2011-06-01)

Chitosan microparticle as a novel adjuvant for avian influenza vaccines
by: Hui-Ting Chen, et al.

Dynamics Analysis of an Avian Influenza A (H7N9) Epidemic Model with Vaccination and Seasonality
by: Juping Zhang, et al.
Published: (2019-01-01)

Comparative efficacy of different adjuvant containing inactivated vaccines against low-pathogenicity Avian Influenza H9N2 virus
by: Aayesha Riaz, et al.
Published: (2017-02-01)

Epidemiological Alert: Avian Influenza - A (H7N9)
by: Eliane Carlosso Krummenauer
Published: (2013-01-01)

Enhancing Immune Response and Heterosubtypic Protection Ability of Inactivated H7N9 Vaccine by Using STING Agonist as a Mucosal Adjuvant
by: Jian Luo, et al.
Published: (2019-09-01)

Comparative Pathogenicity and Transmissibility of the H7N9 Highly Pathogenic Avian Influenza Virus and the H7N9 Low Pathogenic Avian Influenza Virus in Chickens
by: Hao Yu, et al.
Published: (2019-11-01)

Influenza Viral Vectors Expressing Two Kinds of HA Proteins as Bivalent Vaccine Against Highly Pathogenic Avian Influenza Viruses of Clade 2.3.4.4 H5 and H7N9
by: Jinping Li, et al.
Published: (2018-04-01)

Genetic and biological properties of H7N9 avian influenza viruses detected after application of the H7N9 poultry vaccine in China.
by: Xin Yin, et al.
Published: (2021-04-01)

Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.
by: Jiong Wang, et al.
Published: (2018-01-01)

Studies on maternal antibodies to avian influenza H9N2 vaccine
by: M. M. Amer, et al.
Published: (2010-12-01)

EVALUATION OF OIL BASED AVIAN INFLUENZA VACCINE (H5NI) PREPARED WITH DIFFERENT CONCENTRATIONS OF ADJUVANT
by: M. IQBAL, M. NISAR, ANWARUL-HAQ, S. NOOR AND Z. J. GILL
Published: (2008-12-01)

Emerging Role of Mucosal Vaccine in Preventing Infection with Avian Influenza A Viruses
by: Tong Wang, et al.
Published: (2020-08-01)

Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge.
by: Freek Cox, et al.
Published: (2015-01-01)

Avian-to-Human Receptor-Binding Adaptation of Avian H7N9 Influenza Virus Hemagglutinin
by: Ying Xu, et al.
Published: (2019-11-01)

HUMAN INFECTION WITH AVIAN INFLUENZA A (H7N9) VIRUS
by: Yi Zhang, et al.
Published: (2014-07-01)

Prognosis of 18 H7N9 avian influenza patients in Shanghai.
by: Shuihua Lu, et al.
Published: (2014-01-01)

Novel avian H7N9 influenza and its way to humans
by: Viroj Wiwanitkit
Published: (2013-10-01)

Avian Influenza H7N9 Virus Adaptation to Human Hosts
by: Swan Tan, et al.
Published: (2021-05-01)

A Live Attenuated H9N2 Avian Influenza Vaccine Prevents the Viral Reassortment by Exchanging the HA and NS1 Packaging Signals
by: Sujuan Chen, et al.
Published: (2021-02-01)

Nasal vaccination using novel mucosal adjuvants : with main focus on influenza A virus
by: Falkeborn, Tina
Published: (2015)

Immunogenicity of recombinant protein, adenovirus vector and virus-like particles of the avian-origin influenza H7N9 virus hemagglutinin
by: 陳廷軒
Published: (2014)

Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Criteria, Affecting Factors, and Implications for Rational Vaccine Design
by: Zenglei Hu, et al.
Published: (2017-09-01)

Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine
by: Kaito A. Nagashima, et al.
Published: (2021-03-01)

Immunogenicity and Efficacy of Baculovirus Expressing Recombinant H7 Subtypic Influenza HA Virus-like Particles
by: Ro-Lin Chang, et al.
Published: (2011)

Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs.
by: Hae-Ji Kang, et al.
Published: (2019-01-01)

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.
by: Robert B Couch, et al.
Published: (2012-01-01)

Mucosal and Systemic Immune Responses to Influenza H7N9 Antigen HA1–2 Co-Delivered Intranasally with Flagellin or Polyethyleneimine in Mice and Chickens
by: Li Song, et al.
Published: (2017-04-01)

Zika virus envelope domain III recombinant proteins formulated with mucosal adjuvants for vaccine development
by: Wang, Wei-Bo, et al.
Published: (2018)

Recombinant Measles AIK-C Vaccine Strain Expressing Influenza HA Protein
by: Takashi Ito, et al.
Published: (2020-03-01)